Proteomics

Dataset Information

0

Bloodstream infection N-glycoproteomics


ABSTRACT: Here we have performed targeted quantitative N-glycoproteomics from plasma samples of patients with confirmed positive blood culture together with age and sex matched febrile controls with negative blood culture reports. Three hundred and sixty eight potential N-glycopeptides were quantified by mass spectrometry and 149 were further selected for identification. Twenty four N-glycopeptides were identified with high confidence together with elucidation of the peptide sequence, N-glycosylation site, glycan composition and proposed glycan structures. these N-glycopeptides can be used as potential biomarkers of bloodstream infection.

INSTRUMENT(S): Synapt MS

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Plasma

SUBMITTER: Sakari Joenväärä  

LAB HEAD: Risto Renkonen

PROVIDER: PXD009048 | Pride | 2018-04-09

REPOSITORIES: Pride

altmetric image

Publications

Quantitative N-glycoproteomics reveals altered glycosylation levels of various plasma proteins in bloodstream infected patients.

Joenvaara Sakari S   Saraswat Mayank M   Kuusela Pentti P   Saraswat Shruti S   Agarwal Rahul R   Kaartinen Johanna J   Järvinen Asko A   Renkonen Risto R  

PloS one 20180329 3


Bloodstream infections are associated with high morbidity and mortality with rates varying from 10-25% and higher. Appropriate and timely onset of antibiotic therapy influences the prognosis of these patients. It requires the diagnostic accuracy which is not afforded by current gold standards such as blood culture. Moreover, the time from blood sampling to blood culture results is a key determinant of reducing mortality. No established biomarkers exist which can differentiate bloodstream infecti  ...[more]

Similar Datasets

2024-04-25 | PXD042701 | Pride
2021-08-18 | PXD025414 | Pride
2022-12-01 | PXD028607 | Pride
2023-10-19 | PXD030277 | Pride
2017-12-18 | PXD006270 | Pride
2021-05-05 | PXD023951 | Pride
2023-03-04 | PXD020286 | Pride
2020-10-06 | PXD021196 | Pride
2020-04-21 | PXD015622 | Pride
2022-06-29 | PXD031177 | Pride